TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
GLSI

Greenwich Lifesciences Inc

Healthcare · Biotechnology

18.10$ +3.4% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow GLSI
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – –
– +0.0% +0.0% +0.1% +0.1% +0.0% +0.0% +0.0% -50.7%
– – – +247.8% -2.6% +164.0% +36.4% +205.0% -6.2%
– – +0.0% +247.8% -2.6% – – – –
– +8.4% +86.7% -99.0% -1,456.1% – – +3,916.8% +108.6%
– – – – – – -100.0% – +0.0%
– – – – -89.7% -342.3% -100.0% – –
– – +115.0% -267.4% -23.6% – – – –
– – +7.5% +13,763.5% -90.5% -365.8% -100.0% – +174.6%
– – -192.0% – -105.1% – – – –
– – – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?